about
Zika Virus Infection Among U.S. Pregnant Travelers — August 2015–February 2016Interim Guidance for Interpretation of Zika Virus Antibody Test ResultsWest Nile virus RNA in tissues from donor associated with transmission to organ transplant recipientsUpdate: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States (Including U.S. Territories), July 2017.Evaluation of Placental and Fetal Tissue Specimens for Zika Virus Infection - 50 States and District of Columbia, January-December, 2016.Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features.Zika Virus: Common Questions and Answers.Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016.Zika Virus Disease Cases - 50 States and the District of Columbia, January 1-July 31, 2016.St. Louis encephalitis virus possibly transmitted through blood transfusion-Arizona, 2015.Adverse event reports following yellow fever vaccination, 2007-13.Fatal transplant-associated west nile virus encephalitis and public health investigation-california, 2010.Serological Survey for Antibodies to Mosquito-Borne Bunyaviruses Among US National Park Service and US Forest Service Employees.Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009-2012.Ability To Serologically Confirm Recent Zika Virus Infection in Areas with Varying Past Incidence of Dengue Virus Infection in the United States and U.S. Territories in 2016.Modes of Transmission of Zika Virus.Update: Noncongenital Zika Virus Disease Cases - 50 U.S. States and the District of Columbia, 2016.West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2017Expanded Molecular Testing on Patients with Suspected West Nile Virus DiseaseAdverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2012-2016
P50
Q23024073-D1CDA965-0DA1-448E-8555-4B8CEEBEEA50Q24289612-253EE55D-C52E-4D63-A3AE-6912459CA903Q37262405-5818929F-2114-4F8E-86FD-73834404312EQ38157323-A5D412C0-A0EB-40C6-874D-C12CD8855AC8Q38158602-8D8401B5-AA4D-49D8-8C5A-4B8E62CC5154Q38211715-A1B22236-83F8-4F68-B710-937D29806905Q38730425-056A5F91-8C5E-4760-9FBE-B787AE4A9203Q38814254-9C33812C-37EF-4B1E-A021-4C654F08E777Q39386989-BE3D2787-E59C-4778-B1D1-9B0802E4D2C3Q40041866-470FB6FD-44A7-47FA-A6B6-A88C4D84C6D0Q40098397-D049D71D-ACED-42BE-A05C-F18A89888CD2Q40242280-A9FE476F-2BCB-441B-994A-28E6D31D62F0Q40800632-EED9F7E0-B953-4B5F-98F1-409DC7EA9707Q41701215-55B6FA43-4126-45FE-990C-F6C507691355Q43046934-8F401A8F-EFD7-4624-9D70-30683DA8C239Q47266551-F081377F-BC49-4839-BE30-7C839EC8030DQ51336445-9EAD1834-0892-44F8-B655-18B89C57000DQ58589277-D920AACA-7323-4A5A-986F-CB0850261394Q64124423-F2AB72BB-B22C-4469-98ED-12C933A3CFEDQ64137454-22B74A4D-BDFE-4ABA-B460-070B4DD921F6
P50
name
Ingrid B. Rabe
@ast
Ingrid B. Rabe
@en
Ingrid B. Rabe
@nl
type
label
Ingrid B. Rabe
@ast
Ingrid B. Rabe
@en
Ingrid B. Rabe
@nl
altLabel
I B Rabe
@en
I Rabe
@en
I. B. Rabe
@en
I. Rabe
@en
Ingrid B Rabe
@en
Ingrid Rabe
@en
Rabe I
@en
Rabe I. B.
@en
Rabe I.
@en
Rabe IB
@en
prefLabel
Ingrid B. Rabe
@ast
Ingrid B. Rabe
@en
Ingrid B. Rabe
@nl